Green Thumb Industries (GTBIF) Cash from Operations Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) Cash from Operations Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 27.85% |
| 10 | Green Thumb Industries | 1.64 Bn | 1.29 Bn | 143.65 Mn | 0.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48% |
| Dec 31, 2025 | 8.62% |
| Sep 30, 2025 | 15.34% |
| Jun 30, 2025 | 78.12% |
| Mar 31, 2025 | 10.25% |
| Dec 31, 2024 | -4.19% |
| Sep 30, 2024 | 11.41% |
| Jun 30, 2024 | 32.61% |
| Mar 31, 2024 | 28.44% |
| Dec 31, 2023 | 41.94% |
| Sep 30, 2023 | 77.90% |
| Jun 30, 2023 | -17.98% |
| Mar 31, 2023 | 40.31% |
| Dec 31, 2022 | 82.37% |
| Sep 30, 2022 | 126.42% |
| Jun 30, 2022 | -199.61% |
| Mar 31, 2022 | 145.96% |